Medtronic MIRACLE Foreshadows Resynchronized Approach To CHF Therapy
This article was originally published in The Gray Sheet
Executive Summary
A clear clinical benefit demonstrated by Medtronic's InSync atrial synchronous biventricular pacing system in treating congestive heart failure could give FDA the impetus to bring resynchronization therapy to panel review as early as June.